Navigation Links
In'Tech Expands Regulatory Affairs Initiative Globally to Support Its Customers Worldwide
Date:11/12/2019

In’Tech Medical SAS (http://www.intech-medical.com), the leader in contract manufacturing of orthopedic medical devices, today announced the creation of a Global Regulatory Affairs Department, to support Medical Device companies across its facilities.

The reality in the Medical Device industry is that the regulatory element to any Medtech organization is more important than Research & Development, Manufacturing or Sales & Marketing. For a company to contemplate a successful expansion, regulatory affairs conversations and decisions must take place at each stage of the device’s life cycle, ensuring patient safety.

This is true around the world, and Europe is leading the way right now with the new Medical Device Regulation (EU-MDR), causing major disruptions to the regulatory obligations of Original Equipment Manufacturers (OEMs), importers and distributors involved in the medical device distribution chain.

In’Tech Global Regulatory Affairs initiative is precisely designed to help OEMs solve the problem by offering regulatory support as well as a portfolio of turnkey approved products.

“In the past 20 years, In’Tech has constantly innovated in response to market conditions and customer needs,” said Laurent Pruvost, President & CEO of In'Tech Medical. “This global regulatory initiative we are launching continues in that tradition, supporting each of our facilities in USA, France & Malaysia, while focusing on providing customers with all the tools & data to support their product launch. I like to say that we are not in business to sell instruments, but to provide solutions to complicated MedTech conditions. The regulatory environment is definitely becoming more and more complex to navigate, and we are proud to offer solutions setting up our customers for success, thus further improving patient care.”

Thanks to a strong quality & regulatory background, Tania Shammo will lead the initiative as In’Tech’s new Global Regulatory Affairs & Quality Assurance Director. She comes to the position with over two decades of RA/QA experience both in the United States and Internationally, with organizations such as Bradshaw Medical in the US and Leader Biomedical in the Netherlands.

"Tania possesses deep regulatory expertise and has a proven track-record at managing quality assurance and regulatory affairs programs internationally," said Xavier Leroy, In’Tech’s Chief Operating Officer. "In addition to helping the In’Tech Group build rock-solid quality and regulatory foundations, I am confident that her department will also become a key ingredient to many of our customers’ regulatory strategy as they expand.”

You may catch up with In’Tech Team later this week at COA (China Orthopedic Association) in Shanghai, China, November 14-17, booth #8-1J06, Hall 8.2 (ORTHO-Processes Pavilion).

###

About In’Tech Medical
The In’Tech Group is a global leading contract manufacturer of surgical instruments, implants, cases & trays and silicone handles. Powered by 800 employees across the globe, In’Tech is a premiere engineering powerhouse, capable of delivering manufacturing solutions anywhere, at any time. As a healthcare technology innovator, In'Tech is renowned for its portfolio of turnkey designs as well as Wayvio® data-driven asset management solution.

Read the full story at https://www.prweb.com/releases/in_tech_expands_regulatory_affairs_initiative_globally_to_support_its_customers_worldwide/prweb16709686.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. In'Tech Medical Group Announces Remarkable Q1-19 Results
2. The DOE Joint Genome Institute expands capabilities via new partnerships
3. BioForce Nanosciences, Inc. Expands Its Global Market. New partnership with Acugenex Limited
4. DigitalPersona Expands Secure Banking Solutions Portfolio with Software Acquisition
5. Millennium Laboratories Expands Pharmacogenetic Test to Help Clinicians Prescribe the Right Medicine at the Right Dose
6. Binary Biometrics, Founded by James Timothy White, Expands Services to 13+ Locations With the Addition of Owner/Operator Kevin Morris
7. Hartman Foundation expands support for co-op program
8. DRI expands Chinese partnership to address water pollution, management issues
9. Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Centers Clinical Research Division
10. HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars
11. Synaptics TouchView Portfolio Expands with Three New TDDI Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2020)... ... ... Modality Solutions, a biopharmaceutical cold chain validation engineering firm, is ... is the most prestigious ranking of the nation’s fastest-growing private companies. Modality Solutions made ... three-year revenue growth of 71 percent. , The Inc. 5000 list represents a ...
(Date:8/21/2020)... ... August 20, 2020 , ... NDA Partners Chairman ... Clinical Operations executive with expertise in clinical trial planning and feasibility, regulatory inspection ... Expert Consultant. Throughout his career, Mr. Movahhed has helped design and manage oncology, ...
(Date:8/5/2020)... Fla. (PRWEB) , ... August 05, 2020 , ... Regenative ... cover two new innovations, CoreText™ and ProText™, making them the first Wharton’s jelly allografts ... defect using a syringe. The company’s solutions are the first Wharton’s jelly allograft product ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... , ... After research model surgery and catheter implantation, the long journey of ... beginning of a successful study, while protecting and accessing the catheter or device post-surgery ... Surgery from Envigo in a live webinar on Wednesday, August ...
(Date:7/10/2020)... (PRWEB) , ... July 09, ... ... biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has expanded ... broader license allows PathSensors to move into the point-of-care diagnostic market, focusing ...
(Date:7/1/2020)... , ... June 29, 2020 , ... ... to date growth of 40% in 2020, despite many obstacles created as a ... aims to increase revenue for its partnered medical practices and medical manufacturers by ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for treating cancer, today announced the company has entered a license agreement with ... agreement provides Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a ...
Breaking Biology Technology: